AS, L., J, C., E, C., AR, L., P, G., J, Y., . . . E, D. (2011). A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers. Foot & ankle specialist, 4(1), 29. https://doi.org/10.1177/1938640010387417
Chicago Style (17th ed.) CitationAS, Landsman, Cook J, Cook E, Landsman AR, Garrett P, Yoon J, Kirkwood A, and Desman E. "A Retrospective Clinical Study of 188 Consecutive Patients to Examine the Effectiveness of a Biologically Active Cryopreserved Human Skin Allograft (TheraSkin®) on the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers." Foot & Ankle Specialist 4, no. 1 (2011): 29. https://doi.org/10.1177/1938640010387417.
MLA (9th ed.) CitationAS, Landsman, et al. "A Retrospective Clinical Study of 188 Consecutive Patients to Examine the Effectiveness of a Biologically Active Cryopreserved Human Skin Allograft (TheraSkin®) on the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers." Foot & Ankle Specialist, vol. 4, no. 1, 2011, p. 29, https://doi.org/10.1177/1938640010387417.